Basel, 15 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the cobas SARS-CoV-2 Duo for ...

by Roche Molecular Diagnostics The FDA has approved the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, a dual-PCR target HIV-1 viral load test from Roche Molecular Diagnostics. The FDA has ...

reliable and accurate COVID-19 PCR testing beyond the EUA period. Based on continuous analysis performed since the onset of the pandemic, all Roche molecular tests, including the cobas SARS-CoV-2 ...

Developed by Roche scientists, the TAGS technology enhances PCR ... cobas Respiratory flex test is designed to detect and differentiate a range of respiratory viruses in nasopharyngeal swab ...

(RTTNews) - Roche Thursday announced the U.S ... serving as an early predictor of an impending infection. A urine sample stabilised in cobas PCR Media allows the integrity of urine results ...

Roche now offers a comprehensive testing solution allowing critical transplant testing (CMV, EBV, BKV) from a single sample ... cobas BKV are real-time PCR (polymerase chain reaction) tests with ...

New cobas(R) 4800 System designed to increase laboratory efficiency and medical value Roche Diagnostics Canada (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of a new Health Canada ...